Good Life Project Hope, Not Fear: New Conversations on Cancer Breakthroughs | Future of Medicine [Ep. 6]
Dec 8, 2025
Dr. Ross Levine, a physician-scientist at Memorial Sloan Kettering, is at the forefront of cancer research, particularly in blood cancers. He discusses the revolutionary role of AI in early cancer detection and personalized treatments, advocating for patients to explore molecular options. Levine highlights key advancements such as genomic tests and liquid biopsies while emphasizing the impact of lifestyle and the microbiome on cancer risk. His insights illuminate a hopeful future in cancer care, driven by transformative therapies and patient advocacy.
AI Snips
Chapters
Transcript
Episode notes
Cancer Is Many Diseases
- Cancer is not one disease but many molecularly distinct conditions requiring tailored treatments.
- Ross Levine says molecular understanding is the bedrock for more effective, better tolerated therapies.
Be Your Own Best Advocate
- Advocate for yourself and ask your care team whether more molecular testing or expertise is available.
- Ross Levine urges having advocates in your care network to ask critical questions on your behalf.
AI Can Improve Screening Uptake
- AI can encourage people to get screening and make medical guidance more accessible.
- Levine says accurate, AI-driven information can increase patient engagement and screening uptake.